SNX3P1Y

Across TCGA pan-cancer cohorts, SNX3P1Y RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated SNX3P1Y data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher SNX3P1Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNX3P1Y expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

TGCT, KIRP, and LUAD are the cancer types where SNX3P1Y RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	All	0.508	0.991	<.001	108	view →
KIRP	OS	Tertile	All	0.208	0.908	<.001	72	view →
LUAD	DFS	Tertile	All	0.036	0.791	<.001	54	view →
LUSC	OS	Tertile	II,III,IV	0.505	0.743	<.001	45	view →
HNSC	OS	Tertile	IV	0.152	0.733	.002	36	view →
STAD	OS	Tertile	IV	0.111	0.433	.002	27	view →
ESCA	DFS	Tertile	III,IV	0.813	0.274	.033	12	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

SNX3P1Y–TGCT (OS)

Open the TGCT breakdown →